SCIENTURE HOLDINGS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SCIENTURE HOLDINGS, INC. (SCNX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $103.46 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $103.46K, a 36.31% decline year-over-year.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $102.32K, a 23314.19% increase year-over-year.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $162.44K.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $437.00.
- SCIENTURE HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $555.90K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2026-06-30 | $103.46K 10-Q · filed 2026-08-13 | $205.78K derived: sum of 2 quarters · filed 2026-08-13 | |
| 2026-03-31 | $102.32K 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | $555.90K 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $162.44K 10-Q · filed 2026-08-13 | $162.88K derived: sum of 2 quarters · filed 2026-08-13 | |
| 2025-03-31 | $437.00 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |